Fenway Health is pleased to announce that the Health Resources and Services Administration HIV/AIDS Bureau (HRSA/HAB) has awarded The Fenway Institute a groundbreaking four-year cooperative agreement ($5.325 million per year) to establish the Evidence-Informed Interventions Center for Coordinating Technical Assistance, focused on disseminating much-needed interventions for people living with HIV/AIDS.
This national center is part of a new HRSA/HAB initiative entitled: “Using Evidence-Informed Interventions to Improve Health Outcomes for People Living with HIV/AIDS,” designed to identify and implement effective interventions for reducing HIV-related health disparities and improving health outcomes. Desired outcomes include increased retention in care, greater treatment adherence, and better viral suppression for people living with HIV/AIDS.
The interventions will be selected in four priority focus areas: 1) improving HIV health outcomes for transgender women; 2) improving HIV health outcomes for black men who have sex with men; 3) integrating behavioral health with primary medical care for people living with HIV/AIDS; and 4) identifying and addressing trauma among people living with HIV/AIDS.
To help reach these important goals, The Fenway Institute will work collaboratively with HRSA/HAB and our partners at AIDS United to re-grant subawards of up to $170,000 each to 24 Ryan White HIV/AIDS Program recipients to support implementation and sustainability of culturally-tailored interventions. We will also collaborate with a new Evaluation Center, awarded to the University of California at San Francisco (UCSF), which will measure the outcomes and impact of these interventions.
Dr. Alex Keuroghlian, MD, MPH, leads the Division of Education and Training Programs at The Fenway Institute and will direct the Center for Coordinating Technical Assistance: “We are honored to receive this major federal award and inspired by the HIV/AIDS Bureau’s unprecedented investment in national dissemination of the most effective interventions for people living with HIV/AIDS,” said Dr. Keuroghlian. “Our team looks forward to working closely over the next four years with HRSA/HAB, AIDS United, and the Evaluation Center at UCSF to demonstrably improve health outcomes for the most marginalized people living with HIV/AIDS across the United States.”